 | • レポートコード：MRC2012B0003 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、急性心不全（AHF）治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。急性心不全（AHF）治療薬の種類別市場規模（B遮断薬、カルシウムチャネル遮断薬、強心配糖体、利尿薬、モルヒネ、血管拡張薬/硝酸塩、その他）、用途別市場規模（病院、診療所、在宅ケア）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Bayer AG、Orion Corporation、CVie Therapeutics Limited、Bristol-Myers Squibb Company、Novartis AG、Cardiorentis AG、Merck & Co.、Cytokinetics, Inc.、PhaseBio Pharmaceuticals, Inc、 ・地域別グローバル市場分析 2015年-2020年 ・急性心不全（AHF）治療薬の北米市場（アメリカ、カナダ、メキシコ） ・急性心不全（AHF）治療薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・急性心不全（AHF）治療薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・急性心不全（AHF）治療薬の南米市場（ブラジル、アルゼンチン） ・急性心不全（AHF）治療薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：B遮断薬、カルシウムチャネル遮断薬、強心配糖体、利尿薬、モルヒネ、血管拡張薬/硝酸塩、その他 ・用途別分析：病院、診療所、在宅ケア ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Acute Heart Failure (AHF) Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 25.7% in the forecast period of 2020 to 2025 and will expected to reach USD 672.8 million by 2025, from USD 269.8 million in 2019.
The Acute Heart Failure (AHF) Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Acute Heart Failure (AHF) Therapeutics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Acute Heart Failure (AHF) Therapeutics market has been segmented into:
B-Blockers
Calcium Channel Blockers
Cardiac Glycosides
Diuretics
Morphine
Vasodilators/Nitrates
Others
By Application, Acute Heart Failure (AHF) Therapeutics has been segmented into:
Hospital
Clinic
Home Care
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Acute Heart Failure (AHF) Therapeutics market presented in the report. This section sheds light on the sales growth of different regional and country-level Acute Heart Failure (AHF) Therapeutics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Acute Heart Failure (AHF) Therapeutics market.
The report offers in-depth assessment of the growth and other aspects of the Acute Heart Failure (AHF) Therapeutics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Acute Heart Failure (AHF) Therapeutics Market Share Analysis
Acute Heart Failure (AHF) Therapeutics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Acute Heart Failure (AHF) Therapeutics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Acute Heart Failure (AHF) Therapeutics sales, revenue and market share for each player covered in this report.
The major players covered in Acute Heart Failure (AHF) Therapeutics are:
Bayer AG
Orion Corporation
CVie Therapeutics Limited
Bristol-Myers Squibb Company
Novartis AG
Cardiorentis AG
Merck & Co.
Cytokinetics, Inc.
PhaseBio Pharmaceuticals, Inc
Table of Contents
1 Acute Heart Failure (AHF) Therapeutics Market Overview
1.1 Product Overview and Scope of Acute Heart Failure (AHF) Therapeutics
1.2 Classification of Acute Heart Failure (AHF) Therapeutics by Type
1.2.1 Global Acute Heart Failure (AHF) Therapeutics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Acute Heart Failure (AHF) Therapeutics Revenue Market Share by Type in 2019
1.2.3 B-Blockers
1.2.4 Calcium Channel Blockers
1.2.5 Cardiac Glycosides
1.2.6 Diuretics
1.2.7 Morphine
1.2.8 Vasodilators/Nitrates
1.2.9 Others
1.3 Global Acute Heart Failure (AHF) Therapeutics Market by Application
1.3.1 Overview: Global Acute Heart Failure (AHF) Therapeutics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Home Care
1.4 Global Acute Heart Failure (AHF) Therapeutics Market by Regions
1.4.1 Global Acute Heart Failure (AHF) Therapeutics Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Acute Heart Failure (AHF) Therapeutics (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Acute Heart Failure (AHF) Therapeutics Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Acute Heart Failure (AHF) Therapeutics Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Acute Heart Failure (AHF) Therapeutics Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Acute Heart Failure (AHF) Therapeutics Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Acute Heart Failure (AHF) Therapeutics Status and Prospect (2015-2025)
2 Company Profiles
2.1 Bayer AG
2.1.1 Bayer AG Details
2.1.2 Bayer AG Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Bayer AG SWOT Analysis
2.1.4 Bayer AG Product and Services
2.1.5 Bayer AG Acute Heart Failure (AHF) Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.2 Orion Corporation
2.2.1 Orion Corporation Details
2.2.2 Orion Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Orion Corporation SWOT Analysis
2.2.4 Orion Corporation Product and Services
2.2.5 Orion Corporation Acute Heart Failure (AHF) Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.3 CVie Therapeutics Limited
2.3.1 CVie Therapeutics Limited Details
2.3.2 CVie Therapeutics Limited Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 CVie Therapeutics Limited SWOT Analysis
2.3.4 CVie Therapeutics Limited Product and Services
2.3.5 CVie Therapeutics Limited Acute Heart Failure (AHF) Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.4 Bristol-Myers Squibb Company
2.4.1 Bristol-Myers Squibb Company Details
2.4.2 Bristol-Myers Squibb Company Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Bristol-Myers Squibb Company SWOT Analysis
2.4.4 Bristol-Myers Squibb Company Product and Services
2.4.5 Bristol-Myers Squibb Company Acute Heart Failure (AHF) Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.5 Novartis AG
2.5.1 Novartis AG Details
2.5.2 Novartis AG Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Novartis AG SWOT Analysis
2.5.4 Novartis AG Product and Services
2.5.5 Novartis AG Acute Heart Failure (AHF) Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.6 Cardiorentis AG
2.6.1 Cardiorentis AG Details
2.6.2 Cardiorentis AG Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Cardiorentis AG SWOT Analysis
2.6.4 Cardiorentis AG Product and Services
2.6.5 Cardiorentis AG Acute Heart Failure (AHF) Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.7 Merck & Co.
2.7.1 Merck & Co. Details
2.7.2 Merck & Co. Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Merck & Co. SWOT Analysis
2.7.4 Merck & Co. Product and Services
2.7.5 Merck & Co. Acute Heart Failure (AHF) Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.8 Cytokinetics, Inc.
2.8.1 Cytokinetics, Inc. Details
2.8.2 Cytokinetics, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Cytokinetics, Inc. SWOT Analysis
2.8.4 Cytokinetics, Inc. Product and Services
2.8.5 Cytokinetics, Inc. Acute Heart Failure (AHF) Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.9 PhaseBio Pharmaceuticals, Inc
2.9.1 PhaseBio Pharmaceuticals, Inc Details
2.9.2 PhaseBio Pharmaceuticals, Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 PhaseBio Pharmaceuticals, Inc SWOT Analysis
2.9.4 PhaseBio Pharmaceuticals, Inc Product and Services
2.9.5 PhaseBio Pharmaceuticals, Inc Acute Heart Failure (AHF) Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Acute Heart Failure (AHF) Therapeutics Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Acute Heart Failure (AHF) Therapeutics Players Market Share
3.2.2 Top 10 Acute Heart Failure (AHF) Therapeutics Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Acute Heart Failure (AHF) Therapeutics Revenue and Market Share by Regions
4.2 North America Acute Heart Failure (AHF) Therapeutics Revenue and Growth Rate (2015-2020)
4.3 Europe Acute Heart Failure (AHF) Therapeutics Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Acute Heart Failure (AHF) Therapeutics Revenue and Growth Rate (2015-2020)
4.5 South America Acute Heart Failure (AHF) Therapeutics Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Acute Heart Failure (AHF) Therapeutics Revenue and Growth Rate (2015-2020)
5 North America Acute Heart Failure (AHF) Therapeutics Revenue by Countries
5.1 North America Acute Heart Failure (AHF) Therapeutics Revenue by Countries (2015-2020)
5.2 USA Acute Heart Failure (AHF) Therapeutics Revenue and Growth Rate (2015-2020)
5.3 Canada Acute Heart Failure (AHF) Therapeutics Revenue and Growth Rate (2015-2020)
5.4 Mexico Acute Heart Failure (AHF) Therapeutics Revenue and Growth Rate (2015-2020)
6 Europe Acute Heart Failure (AHF) Therapeutics Revenue by Countries
6.1 Europe Acute Heart Failure (AHF) Therapeutics Revenue by Countries (2015-2020)
6.2 Germany Acute Heart Failure (AHF) Therapeutics Revenue and Growth Rate (2015-2020)
6.3 UK Acute Heart Failure (AHF) Therapeutics Revenue and Growth Rate (2015-2020)
6.4 France Acute Heart Failure (AHF) Therapeutics Revenue and Growth Rate (2015-2020)
6.5 Russia Acute Heart Failure (AHF) Therapeutics Revenue and Growth Rate (2015-2020)
6.6 Italy Acute Heart Failure (AHF) Therapeutics Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Acute Heart Failure (AHF) Therapeutics Revenue by Countries
7.1 Asia-Pacific Acute Heart Failure (AHF) Therapeutics Revenue by Countries (2015-2020)
7.2 China Acute Heart Failure (AHF) Therapeutics Revenue and Growth Rate (2015-2020)
7.3 Japan Acute Heart Failure (AHF) Therapeutics Revenue and Growth Rate (2015-2020)
7.4 Korea Acute Heart Failure (AHF) Therapeutics Revenue and Growth Rate (2015-2020)
7.5 India Acute Heart Failure (AHF) Therapeutics Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Acute Heart Failure (AHF) Therapeutics Revenue and Growth Rate (2015-2020)
8 South America Acute Heart Failure (AHF) Therapeutics Revenue by Countries
8.1 South America Acute Heart Failure (AHF) Therapeutics Revenue by Countries (2015-2020)
8.2 Brazil Acute Heart Failure (AHF) Therapeutics Revenue and Growth Rate (2015-2020)
8.3 Argentina Acute Heart Failure (AHF) Therapeutics Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Acute Heart Failure (AHF) Therapeutics by Countries
9.1 Middle East & Africa Acute Heart Failure (AHF) Therapeutics Revenue by Countries (2015-2020)
9.2 Saudi Arabia Acute Heart Failure (AHF) Therapeutics Revenue and Growth Rate (2015-2020)
9.3 UAE Acute Heart Failure (AHF) Therapeutics Revenue and Growth Rate (2015-2020)
9.4 Egypt Acute Heart Failure (AHF) Therapeutics Revenue and Growth Rate (2015-2020)
9.5 South Africa Acute Heart Failure (AHF) Therapeutics Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Acute Heart Failure (AHF) Therapeutics Revenue and Market Share by Type (2015-2020)
10.2 Global Acute Heart Failure (AHF) Therapeutics Market Forecast by Type (2019-2024)
10.3 B-Blockers Revenue Growth Rate (2015-2025)
10.4 Calcium Channel Blockers Revenue Growth Rate (2015-2025)
10.5 Cardiac Glycosides Revenue Growth Rate (2015-2025)
10.6 Diuretics Revenue Growth Rate (2015-2025)
10.7 Morphine Revenue Growth Rate (2015-2025)
10.8 Vasodilators/Nitrates Revenue Growth Rate (2015-2025)
10.9 Others Revenue Growth Rate (2015-2025)
11 Global Acute Heart Failure (AHF) Therapeutics Market Segment by Application
11.1 Global Acute Heart Failure (AHF) Therapeutics Revenue Market Share by Application (2015-2020)
11.2 Acute Heart Failure (AHF) Therapeutics Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2015-2020)
11.4 Clinic Revenue Growth (2015-2020)
11.5 Home Care Revenue Growth (2015-2020)
12 Global Acute Heart Failure (AHF) Therapeutics Market Size Forecast (2021-2025)
12.1 Global Acute Heart Failure (AHF) Therapeutics Market Size Forecast (2021-2025)
12.2 Global Acute Heart Failure (AHF) Therapeutics Market Forecast by Regions (2021-2025)
12.3 North America Acute Heart Failure (AHF) Therapeutics Revenue Market Forecast (2021-2025)
12.4 Europe Acute Heart Failure (AHF) Therapeutics Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Acute Heart Failure (AHF) Therapeutics Revenue Market Forecast (2021-2025)
12.6 South America Acute Heart Failure (AHF) Therapeutics Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Acute Heart Failure (AHF) Therapeutics Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Acute Heart Failure (AHF) Therapeutics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Acute Heart Failure (AHF) Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Acute Heart Failure (AHF) Therapeutics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Acute Heart Failure (AHF) Therapeutics Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Bayer AG Corporate Information, Location and Competitors
Table 6. Bayer AG Acute Heart Failure (AHF) Therapeutics Major Business
Table 7. Bayer AG Acute Heart Failure (AHF) Therapeutics Total Revenue (USD Million) (2017-2018)
Table 8. Bayer AG SWOT Analysis
Table 9. Bayer AG Acute Heart Failure (AHF) Therapeutics Product and Solutions
Table 10. Bayer AG Acute Heart Failure (AHF) Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Orion Corporation Corporate Information, Location and Competitors
Table 12. Orion Corporation Acute Heart Failure (AHF) Therapeutics Major Business
Table 13. Orion Corporation Acute Heart Failure (AHF) Therapeutics Total Revenue (USD Million) (2018-2019)
Table 14. Orion Corporation SWOT Analysis
Table 15. Orion Corporation Acute Heart Failure (AHF) Therapeutics Product and Solutions
Table 16. Orion Corporation Acute Heart Failure (AHF) Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. CVie Therapeutics Limited Corporate Information, Location and Competitors
Table 18. CVie Therapeutics Limited Acute Heart Failure (AHF) Therapeutics Major Business
Table 19. CVie Therapeutics Limited Acute Heart Failure (AHF) Therapeutics Total Revenue (USD Million) (2017-2018)
Table 20. CVie Therapeutics Limited SWOT Analysis
Table 21. CVie Therapeutics Limited Acute Heart Failure (AHF) Therapeutics Product and Solutions
Table 22. CVie Therapeutics Limited Acute Heart Failure (AHF) Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Bristol-Myers Squibb Company Corporate Information, Location and Competitors
Table 24. Bristol-Myers Squibb Company Acute Heart Failure (AHF) Therapeutics Major Business
Table 25. Bristol-Myers Squibb Company Acute Heart Failure (AHF) Therapeutics Total Revenue (USD Million) (2017-2018)
Table 26. Bristol-Myers Squibb Company SWOT Analysis
Table 27. Bristol-Myers Squibb Company Acute Heart Failure (AHF) Therapeutics Product and Solutions
Table 28. Bristol-Myers Squibb Company Acute Heart Failure (AHF) Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Novartis AG Corporate Information, Location and Competitors
Table 30. Novartis AG Acute Heart Failure (AHF) Therapeutics Major Business
Table 31. Novartis AG Acute Heart Failure (AHF) Therapeutics Total Revenue (USD Million) (2017-2018)
Table 32. Novartis AG SWOT Analysis
Table 33. Novartis AG Acute Heart Failure (AHF) Therapeutics Product and Solutions
Table 34. Novartis AG Acute Heart Failure (AHF) Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Cardiorentis AG Corporate Information, Location and Competitors
Table 36. Cardiorentis AG Acute Heart Failure (AHF) Therapeutics Major Business
Table 37. Cardiorentis AG Acute Heart Failure (AHF) Therapeutics Total Revenue (USD Million) (2017-2018)
Table 38. Cardiorentis AG SWOT Analysis
Table 39. Cardiorentis AG Acute Heart Failure (AHF) Therapeutics Product and Solutions
Table 40. Cardiorentis AG Acute Heart Failure (AHF) Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Merck & Co. Corporate Information, Location and Competitors
Table 42. Merck & Co. Acute Heart Failure (AHF) Therapeutics Major Business
Table 43. Merck & Co. Acute Heart Failure (AHF) Therapeutics Total Revenue (USD Million) (2017-2018)
Table 44. Merck & Co. SWOT Analysis
Table 45. Merck & Co. Acute Heart Failure (AHF) Therapeutics Product and Solutions
Table 46. Merck & Co. Acute Heart Failure (AHF) Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Cytokinetics, Inc. Corporate Information, Location and Competitors
Table 48. Cytokinetics, Inc. Acute Heart Failure (AHF) Therapeutics Major Business
Table 49. Cytokinetics, Inc. Acute Heart Failure (AHF) Therapeutics Total Revenue (USD Million) (2017-2018)
Table 50. Cytokinetics, Inc. SWOT Analysis
Table 51. Cytokinetics, Inc. Acute Heart Failure (AHF) Therapeutics Product and Solutions
Table 52. Cytokinetics, Inc. Acute Heart Failure (AHF) Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. PhaseBio Pharmaceuticals, Inc Corporate Information, Location and Competitors
Table 54. PhaseBio Pharmaceuticals, Inc Acute Heart Failure (AHF) Therapeutics Major Business
Table 55. PhaseBio Pharmaceuticals, Inc Acute Heart Failure (AHF) Therapeutics Total Revenue (USD Million) (2017-2018)
Table 56. PhaseBio Pharmaceuticals, Inc SWOT Analysis
Table 57. PhaseBio Pharmaceuticals, Inc Acute Heart Failure (AHF) Therapeutics Product and Solutions
Table 58. PhaseBio Pharmaceuticals, Inc Acute Heart Failure (AHF) Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Global Acute Heart Failure (AHF) Therapeutics Revenue (Million USD) by Players (2015-2020)
Table 60. Global Acute Heart Failure (AHF) Therapeutics Revenue Share by Players (2015-2020)
Table 61. Global Acute Heart Failure (AHF) Therapeutics Revenue (Million USD) by Regions (2015-2020)
Table 62. Global Acute Heart Failure (AHF) Therapeutics Revenue Market Share by Regions (2015-2020)
Table 63. North America Acute Heart Failure (AHF) Therapeutics Revenue by Countries (2015-2020)
Table 64. North America Acute Heart Failure (AHF) Therapeutics Revenue Market Share by Countries (2015-2020)
Table 65. Europe Acute Heart Failure (AHF) Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 66. Asia-Pacific Acute Heart Failure (AHF) Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 67. South America Acute Heart Failure (AHF) Therapeutics Revenue by Countries (2015-2020)
Table 68. South America Acute Heart Failure (AHF) Therapeutics Revenue Market Share by Countries (2015-2020)
Table 69. Middle East and Africa Acute Heart Failure (AHF) Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 70. Middle East and Africa Acute Heart Failure (AHF) Therapeutics Revenue Market Share by Countries (2015-2020)
Table 71. Global Acute Heart Failure (AHF) Therapeutics Revenue (Million USD) by Type (2015-2020)
Table 72. Global Acute Heart Failure (AHF) Therapeutics Revenue Share by Type (2015-2020)
Table 73. Global Acute Heart Failure (AHF) Therapeutics Revenue Forecast by Type (2021-2025)
Table 74. Global Acute Heart Failure (AHF) Therapeutics Revenue by Application (2015-2020)
Table 75. Global Acute Heart Failure (AHF) Therapeutics Revenue Share by Application (2015-2020)
Table 76. Global Acute Heart Failure (AHF) Therapeutics Revenue Forecast by Application (2021-2025)
Table 77. Global Acute Heart Failure (AHF) Therapeutics Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Acute Heart Failure (AHF) Therapeutics Picture
Figure 2. Global Acute Heart Failure (AHF) Therapeutics Revenue Market Share by Type in 2019
Figure 3. B-Blockers Picture
Figure 4. Calcium Channel Blockers Picture
Figure 5. Cardiac Glycosides Picture
Figure 6. Diuretics Picture
Figure 7. Morphine Picture
Figure 8. Vasodilators/Nitrates Picture
Figure 9. Others Picture
Figure 10. Acute Heart Failure (AHF) Therapeutics Revenue Market Share by Application in 2019
Figure 11. Hospital Picture
Figure 12. Clinic Picture
Figure 13. Home Care Picture
Figure 14. Global Acute Heart Failure (AHF) Therapeutics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 15. North America Acute Heart Failure (AHF) Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Europe Acute Heart Failure (AHF) Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Asia-Pacific Acute Heart Failure (AHF) Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. South America Acute Heart Failure (AHF) Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Middle East and Africa Acute Heart Failure (AHF) Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Global Acute Heart Failure (AHF) Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Global Acute Heart Failure (AHF) Therapeutics Revenue Share by Players in 2019
Figure 22. Global Top 5 Players Acute Heart Failure (AHF) Therapeutics Revenue Market Share in 2019
Figure 23. Global Top 10 Players Acute Heart Failure (AHF) Therapeutics Revenue Market Share in 2019
Figure 24. Key Players Market Share Trend
Figure 25. Global Acute Heart Failure (AHF) Therapeutics Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 26. Global Acute Heart Failure (AHF) Therapeutics Revenue Market Share by Regions (2015-2020)
Figure 27. Global Acute Heart Failure (AHF) Therapeutics Revenue Market Share by Regions in 2018
Figure 28. North America Acute Heart Failure (AHF) Therapeutics Revenue and Growth Rate (2015-2020)
Figure 29. Europe Acute Heart Failure (AHF) Therapeutics Revenue and Growth Rate (2015-2020)
Figure 30. Asia-Pacific Acute Heart Failure (AHF) Therapeutics Revenue and Growth Rate (2015-2020)
Figure 31. South America Acute Heart Failure (AHF) Therapeutics Revenue and Growth Rate (2015-2020)
Figure 32. Middle East and Africa Acute Heart Failure (AHF) Therapeutics Revenue and Growth Rate (2015-2020)
Figure 33. North America Acute Heart Failure (AHF) Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 34. North America Acute Heart Failure (AHF) Therapeutics Revenue Market Share by Countries in 2019
Figure 35. USA Acute Heart Failure (AHF) Therapeutics Revenue and Growth Rate (2015-2020)
Figure 36. Canada Acute Heart Failure (AHF) Therapeutics Revenue and Growth Rate (2015-2020)
Figure 37. Mexico Acute Heart Failure (AHF) Therapeutics Revenue and Growth Rate (2015-2020)
Figure 38. Europe Acute Heart Failure (AHF) Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 39. Europe Acute Heart Failure (AHF) Therapeutics Revenue Market Share by Countries in 2019
Figure 40. Germany Acute Heart Failure (AHF) Therapeutics Revenue and Growth Rate (2015-2020)
Figure 41. UK Acute Heart Failure (AHF) Therapeutics Revenue and Growth Rate (2015-2020)
Figure 42. France Acute Heart Failure (AHF) Therapeutics Revenue and Growth Rate (2015-2020)
Figure 43. Russia Acute Heart Failure (AHF) Therapeutics Revenue and Growth Rate (2015-2020)
Figure 44. Italy Acute Heart Failure (AHF) Therapeutics Revenue and Growth Rate (2015-2020)
Figure 45. Asia-Pacific Acute Heart Failure (AHF) Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 46. Asia-Pacific Acute Heart Failure (AHF) Therapeutics Revenue Market Share by Countries in 2019
Figure 47. China Acute Heart Failure (AHF) Therapeutics Revenue and Growth Rate (2015-2020)
Figure 48. Japan Acute Heart Failure (AHF) Therapeutics Revenue and Growth Rate (2015-2020)
Figure 49. Korea Acute Heart Failure (AHF) Therapeutics Revenue and Growth Rate (2015-2020)
Figure 50. India Acute Heart Failure (AHF) Therapeutics Revenue and Growth Rate (2015-2020)
Figure 51. Southeast Asia Acute Heart Failure (AHF) Therapeutics Revenue and Growth Rate (2015-2020)
Figure 52. South America Acute Heart Failure (AHF) Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 53. South America Acute Heart Failure (AHF) Therapeutics Revenue Market Share by Countries in 2019
Figure 54. Brazil Acute Heart Failure (AHF) Therapeutics Revenue and Growth Rate (2015-2020)
Figure 55. Argentina Acute Heart Failure (AHF) Therapeutics Revenue and Growth Rate (2015-2020)
Figure 56. Middle East and Africa Acute Heart Failure (AHF) Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 57. Middle East and Africa Acute Heart Failure (AHF) Therapeutics Revenue Market Share by Countries in 2019
Figure 58. Saudi Arabia Acute Heart Failure (AHF) Therapeutics Revenue and Growth Rate (2015-2020)
Figure 59. UAE Acute Heart Failure (AHF) Therapeutics Revenue and Growth Rate (2015-2020)
Figure 60. Egypt Acute Heart Failure (AHF) Therapeutics Revenue and Growth Rate (2015-2020)
Figure 61. South Africa Acute Heart Failure (AHF) Therapeutics Revenue and Growth Rate (2015-2020)
Figure 62. Global Acute Heart Failure (AHF) Therapeutics Revenue Share by Type (2015-2020)
Figure 63. Global Acute Heart Failure (AHF) Therapeutics Revenue Share by Type in 2019
Figure 64. Global Acute Heart Failure (AHF) Therapeutics Market Share Forecast by Type (2021-2025)
Figure 65. Global B-Blockers Revenue Growth Rate (2015-2020)
Figure 66. Global Calcium Channel Blockers Revenue Growth Rate (2015-2020)
Figure 67. Global Cardiac Glycosides Revenue Growth Rate (2015-2020)
Figure 68. Global Diuretics Revenue Growth Rate (2015-2020)
Figure 69. Global Morphine Revenue Growth Rate (2015-2020)
Figure 70. Global Vasodilators/Nitrates Revenue Growth Rate (2015-2020)
Figure 71. Global Others Revenue Growth Rate (2015-2020)
Figure 72. Global Acute Heart Failure (AHF) Therapeutics Revenue Share by Application (2015-2020)
Figure 73. Global Acute Heart Failure (AHF) Therapeutics Revenue Share by Application in 2019
Figure 74. Global Acute Heart Failure (AHF) Therapeutics Market Share Forecast by Application (2021-2025)
Figure 75. Global Hospital Revenue Growth Rate (2015-2020)
Figure 76. Global Clinic Revenue Growth Rate (2015-2020)
Figure 77. Global Home Care Revenue Growth Rate (2015-2020)
Figure 78. Global Acute Heart Failure (AHF) Therapeutics Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 79. Global Acute Heart Failure (AHF) Therapeutics Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 80. Global Acute Heart Failure (AHF) Therapeutics Revenue Market Share Forecast by Regions (2021-2025)
Figure 81. North America Acute Heart Failure (AHF) Therapeutics Revenue Market Forecast (2021-2025)
Figure 82. Europe Acute Heart Failure (AHF) Therapeutics Revenue Market Forecast (2021-2025)
Figure 83. Asia-Pacific Acute Heart Failure (AHF) Therapeutics Revenue Market Forecast (2021-2025)
Figure 84. South America Acute Heart Failure (AHF) Therapeutics Revenue Market Forecast (2021-2025)
Figure 85. Middle East and Africa Acute Heart Failure (AHF) Therapeutics Revenue Market Forecast (2021-2025)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
急性心不全（AHF）治療薬の世界市場（～2026年） Market Analysis and Insights: Global Acute Heart Failure (AHF) Therapeutics Market The global Acute Heart Failure (AHF) Therapeutics market size is projected to reach US$ 336 million by 2026, from US$ 262.2 million in 2020, at a CAGR of 26.8%% during 2021-2026. Global Acute Heart Failure (AHF) Thera…- 急性腎不全治療薬の世界市場（～2026年） Acute renal failure is a sudden loss of kidney’s ability to eliminate excess fluids, salts and metabolic waste from the body. It leads to accumulation of metabolic waste and electrolytes in the body which can be life-threatening. Kidney eliminates creatinine (Metabolic waste) from the body. Acute re…
- 心不全治療薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Heart Failure Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, t…
- 心不全監視ソフトウェアの世界市場（～2026年） Market Analysis and Insights: Global Heart Failure Mornitoring Software Market The global Heart Failure Mornitoring Software market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Heart Failure Mornitoring Software Scope and …
- うっ血性心不全（CHF）の世界市場（～2026年） Market Analysis and Insights: Global Congestive Heart Failure (CHF) Market The global Congestive Heart Failure (CHF) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Congestive Heart Failure (CHF) Scope and Market Size …